Deal with Oklahoma by Purdue Pharma and Sackler family owners could be first of many

Legal pivot tees up fierce fight with Democrats over healthcare in 2020 race

Court rules that critic of HPV vaccine did not fabricate his research

Biotech’s shares tumbled last week after it halted trials of promising Alzheimer’s therapy

Move by major funder comes as arts organisations face pressure to stop accepting its gifts

Hospitals ‘beg and borrow’ for staff as consultants cut hours fearing huge tax bills

The UK’s chief medical officer on the NHS, drug resistance and global health

Our columnist is worried about his lack of training as the London Marathon looms

Analysts say value of demerged unit would be roughly £2bn

Biogen’s aducanumab was last hope of one approach to the disease, but there are others

Officials launch crisis management plan and monitors supplies of food and key utilities

Drugmaker loses $18bn from market value after deciding to discontinue trials

Worries over cost of glyphosate cancer link wipe €25bn from market value

Skills of other staff should be used to plug GP shortfall and living grants given to nurses

Crowdfunders face scrutiny over unproven medical treatments

US court finds weedkiller had been ‘substantial factor’ in causing cancer of plaintiff

Pharma chiefs see ‘lack of focus’ in protecting sector after Britain’s departure

French online medical appointment management service cements its ‘unicorn’ status

Fallout from US opioid health crisis reaches London art world